Ayurvedic formulation for impairment of thinking memory and language due to aging process
Phase 2
- Conditions
- Health Condition 1: R418- Other symptoms and signs involvingcognitive functions and awareness
- Registration Number
- CTRI/2022/11/047583
- Lead Sponsor
- Dr Tasni Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age above 50 years of either sex
2. Participants Diagnosed Mild NCD as per DSM V Criteria
3. Those who are MMSE score lies between 19-23.
4. Montreal cognitive assessment scale (MOCA <22)
Exclusion Criteria
1.Other Neurocognitive Disorders due to Parkinsonâ??s disease, Huntingtonâ??s disease
2.Neuropsychiatric disorders such as Schizophrenia, Bipolar mood disorder,
Other neurotic disorders
3.Systemic illnesses like known cases of Thyroid disorders, Hyper lipidemia,
Uncontrolled Diabetes and Hypertension
4.Patient with substance abuse like alcohol tobacco etc
5.Patients with clinically relevant depression.
[Cornell scale for depression in Dementia (CSDD) >10
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effecacy of Kushmandaka Ghritha on Mini mental state examination (MMSE), Montreal cognitive assessment scale (MOCA), Disability Assessment for Dementia (DAD)-Functional assessment, Cornell Scale for Depression in Dementia (CSDD), DEMQOL â??quality of life, <br/ ><br>Regensburg Insomnia scale for Assessment of psychological symptoms & sleep in insomniaTimepoint: Baseline, day 30 and day 60 <br/ ><br>
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI